The White House has scheduled four meetings on FDA’s pending CBD compliance and enforcement policy. That does not make the rules final, but it is a real federal signal that labels, claims, and distribution risk deserve a fresh review.

The White House has scheduled an April 1 review of FDA’s proposed CBD compliance and enforcement policy. That does not make the rules final, but it is a real federal signal that labeling, claims, and distribution risk deserve a fresh look.

Michigan filed formal enforcement complaints against a licensed cannabis testing lab, raising data integrity and COA reliability concerns. For operators, this is a reminder to tighten traceability, diversify lab exposure, and stay recall ready.

A Colorado health advisory triggered a voluntary recall after a cannabis concentrate batch that initially passed testing was later found to contain chlorfenapyr above limits. Here is the operator checklist to respond fast and tighten lab risk controls.

California issued a final condemnation order requiring destruction of embargoed inventory after inspectors documented missing UID traceability and unsourced materials. The lesson is simple: track and trace is the product.

California issued a voluntary recall for Luigi integrated vaporizers after DCC said the distillate could not be traced to a verified source. The operator lesson is simple: traceability is the product.

Oklahoma issued a mandatory recall tied to unreliable yeast and mold testing results from a licensed lab. Here is the operator playbook to audit by batch number, quarantine fast, and stay inspection ready.

Washington is treating packaging and labeling as inspection ready compliance, not optional guidance. Here is what WAC 314 55 requires for Not for kids symbols, universal symbols, and inhalable ingredient disclosure, plus a weekly checklist to stay ahead.

The IRS says Section 280E still applies because cannabis rescheduling is not final. Here is what operators should do now to protect cash flow, documentation, and lender confidence.

No new DEA rescheduling final rule has been published during this window, so cannabis remains Schedule I at the federal government level. Here is the operator plan: keep executing under today’s rules and stay ready to pivot if a final rule lands.